1. Antitumor activity and other biologic properties of l-asparaginase (NSC-109229)—a review;Adamson;Cancer Chemother Rep,1968
2. Dose reduction of asparaginase under pharmacokinetik and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia;Ahlke;Br J Hematol,1997
3. Stereospecific asparaginases in smooth Brucella abortus strain 19;Altenbern;Arch Biochem Biophys,1954
4. Relative toxicity of E. coli l-asparaginase (ASP) and PEGasparaginase (PEG) in newly diagnosed chidhood acute lymphoblastic leukemia (ALL);Asselin;Med Pediatr Oncol,1993
5. Comparative pharmacokinetic studies of three asparaginase preparations;Asselin;J Clin Oncol,1993